Biochemical analysis of human milk treated with sodium dodecyl sulfate, an alkyl sulfate microbicide that inactivates human immunodeficiency virus type 1.
Journal
  Journal of human lactation : official journal of International Lactation Consultant Association.
Citation
  J Hum Lact. 22(1):61-74
Publication date
  2006 Feb
Authors
  Hartmann SU
Wigdahl B
Neely EB
Berlin CM
Schengrund CL
Lin HM
Howett MK
Investigators
  Cheston M. Berlin, Jr.
Hung-Mo Lin
Cara-Lynne Schengrund
Grant agencies
  National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
Grants
  NICHD F32 HD41346
NIAID PO1 AI37829
MeSH headings
  Disease Transmission, Vertical
HIV Infections
HIV-1
Milk, Human
Sodium Dodecyl Sulfate
MeSH qualifiers
  prevention & control
transmission
drug effects
pharmacology
Abstract
  Reduction of transmission of human immunodeficiency virus type 1 (HIV-1) through human milk is needed. Alkyl sulfates such as sodium dodecyl sulfate (SDS) are microbicidal against HIV-1 at low concentrations, have little to no toxicity, and are inexpensive. The authors have reported that treatment of HIV-1-infected human milk with < or = 1% (10 mg/mL) SDS for 10 minutes inactivates cell-free and cell-associated virus. The SDS can be removed with a commercially available resin after treatment without recovery of viral infectivity. In this article, the authors report results of selective biochemical analyses (ie, protein, immunoglobulins, lipids, cells, and electrolytes) of human milk subjected to SDS treatment and removal. The SDS treatment or removal had no significant effects on the milk components studied. Therefore, the use of alkyl sulfate microbicides to treat milk from HIV-1-positive women may be a simple, practical, and nutritionally sound way to prevent or reduce transmission of HIV-1 while still feeding with mother's own milk.